No Data
No Data
Genprex to Present Results Preclinical Data From Reqorsa Study
Genprex Collaborators Selected to Present Positive Preclinical Data on Diabetes Gene Therapy at the 2025 American Diabetes Association 85th Scientific Sessions
Trending Stocks Today | Regencell Bioscience Soars 51.18% Pre-Market
Why Harrow Shares Are Trading Higher By 23%; Here Are 20 Stocks Moving Premarket
Genprex to Participate at BIO Europe Spring 2025
Enprex Announces Strategic CDMO Collaboration For Diabetes Gene Therapy Using Non-Viral Delivery System